Adicet Bio, Inc. — Director's Dealing 2022

Jan 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-01-07

Reporting Person: Aftab Blake (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-07	Stock Option (Right to Buy)	$15.52	A	125000	Acquired	2032-01-06	Common Stock (125000)	Direct

Footnotes

F1: 25% of the shares shall vest on the first anniversary of January 7, 2022 and, thereafter, the remainder of the shares shall vest in 36 equal monthly installments, provided that the Reporting Person maintains a service relationship with the Company as of the applicable vesting dates.